Federal Register Notice: FDA is making available a guidance for industry entitled Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients on the types of toxicity information that FDA recommends sponsor provide to the agency to support using new excipients in drug products. This information has not been available to drug sponsors in a written document previously. To download this guidance, click here. To view this notice, click here.
